|
市場調査レポート
商品コード
1548181
止血剤・組織封鎖剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測Global Hemostasis and Tissue Sealing Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
カスタマイズ可能
|
|||||||
| 止血剤・組織封鎖剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測 |
|
出版日: 2024年08月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
止血剤・組織封鎖剤市場の世界需要は、2023年の85億2,000万米ドルから2032年には193億1,000万米ドル近くの市場規模に達すると推定され、調査期間2024年～2032年のCAGRは9.51%です。
止血剤・組織封鎖剤は、外科手術中の出血を抑え、組織の修復を促進するために使用される医療用製品です。局所止血剤、シーラント、接着剤などを含むこれらの薬剤は、血栓形成を促進したり組織を密封したりすることで出血を迅速に止めるように設計されています。様々な外科専門分野で一般的に使用されているこれらの薬剤は、コラーゲンやフィブリンなどの生物学的材料に由来するもの、あるいは合成のものがあります。その主な機能は、出血に関連した合併症を減らし、治癒を早めることで手術成績を高めることです。これらの製品は、効果的な止血と確実な組織接着を達成するために、出血部位や組織界面に直接塗布されます。
市場力学
止血・組織シーリング剤市場は、心臓血管外科、整形外科、一般外科など多様な医療分野における外科手術の増加によって活性化しています。出血を管理し回復を促進するために効果的な止血・封鎖ソリューションを必要とする低侵襲手術の需要が高まっていることが、市場の成長をさらに後押ししています。有効性と生体適合性を向上させた高度なシーラント製剤の開発など、技術的進歩が大きなチャンスをもたらしています。革新的な止血製品によって外科的合併症を減らし、患者の転帰を改善することに重点を置くことが、市場の拡大を後押ししています。さらに、外科的介入を必要とする慢性疾患や外傷症例の増加が、これらの薬剤の使用増加に寄与しています。ヘルスケアのインフラと手術能力の拡大に伴い、新興市場も止血剤・組織封鎖剤の成長ポテンシャルを提供しています。しかし、高コストと潜在的なアレルギー反応が止血剤・組織封鎖剤の成長を抑制する可能性があります。
この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、止血剤および組織封鎖剤の世界市場における各セグメントを包括的に評価することもできます。止血剤および組織封鎖剤業界の成長と動向は、この調査に全体的なアプローチを提供します。
市場セグメンテーション
止血剤および組織シーリング剤市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後のビジネスチャンスを支援します。
製品別
- 局所止血剤（活性型、機械型、流動型）
- 接着剤・組織シーラント（合成組織シーラント、天然組織シーラント、接着バリア製品）
材料別
- ゼラチンベースの局所止血材
- コラーゲン系止血材
- ORC系止血材
- 多糖類ベースの局所止血材
用途別
- 一般外科
- 脳神経外科
- 血管外科
- 心臓血管外科
- その他
用途別
- 病院
- 外来手術センター
- その他
地域別分析
本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおける止血剤および組織封鎖剤市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要・推定・予測に焦点を当てています。
カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 止血剤・組織封鎖剤- 産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカーリスト
- 主要原材料の価格動向
- 潜在的バイヤーのリスト
- マーケティングチャネル
- ダイレクトマーケティング
- インダイレクトマーケティング
- マーケティングチャネル発展動向
第5章 止血・組織封鎖剤の世界市場分析：製品別
- 製品別概要
- 製品別の過去および予測データ分析
- 局所止血剤（活性型、機械型、流動型）
- 接着剤・組織封鎖剤（合成組織封鎖剤、天然組織封鎖剤、接着バリア製品）
第6章 止血剤・組織封鎖剤の世界市場分析：材料別
- 材料別概要
- 材料別の過去および予測データ分析
- ゼラチンベースの局所止血材
- コラーゲン系局所止血材
- ORCベースの局所止血材
- 多糖類ベースの局所用止血材
第7章 止血剤・組織封鎖剤の世界市場分析：用途別
- 概要：用途別
- 過去および予測データ分析：用途別
- 一般外科
- 脳神経外科
- 血管外科
- 心臓血管外科
- その他
第8章 止血・組織シーリング剤の世界市場分析：最終用途別
- 最終用途別概要
- 最終用途別過去および予測データ分析
- 病院
- 外来手術センター
- その他
第9章 止血剤・組織封鎖剤の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州セグメント別
- 欧州国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他欧州
- アジア太平洋売上分析
- 概要、実績と予測
- アジア太平洋セグメント別
- アジア太平洋国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他アジア太平洋
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカセグメント別
- ラテンアメリカ国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他ラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカセグメント別
- 中東・アフリカ国別一覧
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
第10章 止血・組織シーリング剤企業の競合情勢
- 止血・組織シーリング剤市場の競合
- 提携・協力・協定
- 合併・買収
- 新製品の上市
- その他の開発
第11章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Johnson & Johnson
- CryoLife Inc.
- Advance Medical Solution（AMS）Group Plc.
- Cohera Medical Inc.
- Integra Life Sciences Corporation
- Pfizer Inc.
- BD
- Baxter
- HyperBranch Medical Technology
- Biomet Inc
- B Braun Medical Inc
- Smith & Nephew
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product (USD MN)
- Topical Hemostat (Active, Mechanical, Flowable) Market Sales By Geography (USD MN)
- Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Market Sales By Geography (USD MN)
- Analysis By Material (USD MN)
- Gelatin-Based Topical Hemostats Market Sales By Geography (USD MN)
- Collagen-Based Topical Hemostats Market Sales By Geography (USD MN)
- ORC-based Topical Hemostats Market Sales By Geography (USD MN)
- Polysaccharide-Based Topical Hemostats Market Sales By Geography (USD MN)
- Analysis By Application (USD MN)
- General Surgery Market Sales By Geography (USD MN)
- Neurosurgery Market Sales By Geography (USD MN)
- Vascular Surgery Market Sales By Geography (USD MN)
- Cardiovascular Surgery Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By End-use (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Ambulatory Surgical Centers Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Hemostasis and Tissue Sealing Agents Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Hemostasis and Tissue Sealing Agents Report
- Market Research Process
- Market Research Methodology
- Global Hemostasis and Tissue Sealing Agents Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product
- Market Attractiveness Analysis By Material
- Market Attractiveness Analysis By Application
- Market Attractiveness Analysis By End-use
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product (USD MN)
- Topical Hemostat (Active, Mechanical, Flowable) Market Sales By Geography (USD MN)
- Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Market Sales By Geography (USD MN)
- Global Market Analysis By Material (USD MN)
- Gelatin-Based Topical Hemostats Market Sales By Geography (USD MN)
- Collagen-Based Topical Hemostats Market Sales By Geography (USD MN)
- ORC-based Topical Hemostats Market Sales By Geography (USD MN)
- Polysaccharide-Based Topical Hemostats Market Sales By Geography (USD MN)
- Global Market Analysis By Application (USD MN)
- General Surgery Market Sales By Geography (USD MN)
- Neurosurgery Market Sales By Geography (USD MN)
- Vascular Surgery Market Sales By Geography (USD MN)
- Cardiovascular Surgery Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By End-use (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Ambulatory Surgical Centers Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for Hemostasis and Tissue Sealing Agents Market is presumed to reach the market size of nearly USD 19.31 Billion by 2032 from USD 8.52 Billion in 2023 with a CAGR of 9.51% under the study period 2024-2032.
Hemostasis and tissue sealing agents are medical products utilized to control bleeding and facilitate tissue repair during surgical procedures. These agents, including topical hemostats, sealants, and adhesives, are designed to quickly stop bleeding by promoting clot formation or sealing tissues. Commonly used in various surgical specialties, these agents can be derived from biological materials, such as collagen or fibrin, or be synthetic. Their primary function is to enhance surgical outcomes by reducing bleeding-related complications and promoting faster healing. These products are applied directly to the bleeding site or tissue interface to achieve effective hemostasis and secure tissue adhesion.
MARKET DYNAMICS
The hemostasis and tissue sealing agents market is fuelled by the increasing number of surgical procedures across diverse medical fields, including cardiovascular, orthopedic, and general surgery. The propelling demand for minimally invasive surgeries, which require effective hemostatic and sealing solutions to manage bleeding and enhance recovery, further supports market growth. Technological advancements, such as developing advanced sealant formulations with improved efficacy and biocompatibility, present significant opportunities. The focus on reducing surgical complications and improving patient outcomes through innovative hemostatic products drives market expansion. Additionally, the growing prevalence of chronic conditions and trauma cases that necessitate surgical intervention contributes to the increased use of these agents. With expanding healthcare infrastructure and surgical capabilities, emerging markets also offer growth potential for hemostasis and tissue sealing agents. However, high costs and potential allergic reactions may restrain the growth of hemostasis and tissue sealing agents.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hemostasis and Tissue Sealing Agents. The growth and trends of Hemostasis and Tissue Sealing Agents industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Hemostasis and Tissue Sealing Agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Topical Hemostat (Active, Mechanical, Flowable)
- Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products)
By Material
- Gelatin-Based Topical Hemostats
- Collagen-Based Topical Hemostats
- ORC-based Topical Hemostats
- Polysaccharide-Based Topical Hemostats
By Application
- General Surgery
- Neurosurgery
- Vascular Surgery
- Cardiovascular Surgery
- Others
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Hemostasis and Tissue Sealing Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hemostasis and Tissue Sealing Agents market include Johnson & Johnson, CryoLife Inc., Advance Medical Solution (AMS) Group Plc., Cohera Medical Inc., Integra Life Sciences Corporation, Pfizer Inc., BD, Baxter, HyperBranch Medical Technology, Biomet Inc, B Braun Medical Inc, Smith & Nephew. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. HEMOSTASIS AND TISSUE SEALING AGENTS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Material
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY PRODUCT
- 5.1. Overview By Product
- 5.2. Historical and Forecast Data Analysis By Product
- 5.3. Topical Hemostat (Active, Mechanical, Flowable) Historic and Forecast Sales By Regions
- 5.4. Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Historic and Forecast Sales By Regions
6. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY MATERIAL
- 6.1. Overview By Material
- 6.2. Historical and Forecast Data Analysis By Material
- 6.3. Gelatin-Based Topical Hemostats Historic and Forecast Sales By Regions
- 6.4. Collagen-Based Topical Hemostats Historic and Forecast Sales By Regions
- 6.5. ORC-based Topical Hemostats Historic and Forecast Sales By Regions
- 6.6. Polysaccharide-Based Topical Hemostats Historic and Forecast Sales By Regions
7. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY APPLICATION
- 7.1. Overview By Application
- 7.2. Historical and Forecast Data Analysis By Application
- 7.3. General Surgery Historic and Forecast Sales By Regions
- 7.4. Neurosurgery Historic and Forecast Sales By Regions
- 7.5. Vascular Surgery Historic and Forecast Sales By Regions
- 7.6. Cardiovascular Surgery Historic and Forecast Sales By Regions
- 7.7. Others Historic and Forecast Sales By Regions
8. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY END-USE
- 8.1. Overview By End-use
- 8.2. Historical and Forecast Data Analysis By End-use
- 8.3. Hospitals Historic and Forecast Sales By Regions
- 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
- 8.5. Others Historic and Forecast Sales By Regions
9. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE HEMOSTASIS AND TISSUE SEALING AGENTS COMPANIES
- 10.1. Hemostasis and Tissue Sealing Agents Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11. COMPANY PROFILES OF HEMOSTASIS AND TISSUE SEALING AGENTS INDUSTRY
- 11.1. Top Companies Market Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Johnson & Johnson
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
- 11.4. CryoLife Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
- 11.5. Advance Medical Solution (AMS) Group Plc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
- 11.6. Cohera Medical Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
- 11.7. Integra Life Sciences Corporation
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
- 11.8. Pfizer Inc.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
- 11.9. BD
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
- 11.10. Baxter
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
- 11.11. HyperBranch Medical Technology
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
- 11.12. Biomet Inc
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
- 11.13. B Braun Medical Inc
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
- 11.14. Smith & Nephew
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
